Amalgamated Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.44M Sell
56,688
-2,323
-4% -$158K 0.03% 494
2026
Q1
$3.81M Buy
59,011
+1,528
+3% +$108K 0.03% 524
2025
Q4
$3.87M Buy
57,483
+67
+0.1% +$4.51K 0.03% 522
2025
Q3
$4.21M Sell
57,416
-1,822
-3% -$121K 0.03% 496
2025
Q2
$3.08M Buy
59,238
+3,313
+6% +$189K 0.02% 608
2025
Q1
$3.57M Sell
55,925
-2,116
-4% -$123K 0.03% 520
2024
Q4
$2.77M Hold
58,041
0.02% 668
2024
Q3
$3.32M Sell
58,041
-3,636
-6% -$208K 0.03% 588
2024
Q2
$3.23M Sell
61,677
-7,486
-11% -$328K 0.03% 643
2024
Q1
$2.81M Sell
69,163
-13,596
-16% -$510K 0.02% 725
2023
Q4
$3.06M Sell
82,759
-1,042
-1% -$39.2K 0.02% 736
2023
Q3
$3.2M Sell
83,801
-2,574
-3% -$105K 0.03% 662
2023
Q2
$3.12M Sell
86,375
-3,855
-4% -$132K 0.03% 676
2023
Q1
$3.45M Sell
90,230
-4,939
-5% -$232K 0.03% 629
2022
Q4
$5.42M Sell
95,169
-286
-0.3% -$14.6K 0.05% 425
2022
Q3
$3.77M Buy
95,455
+1,878
+2% +$83K 0.04% 533
2022
Q2
$4.12M Sell
93,577
-1,731
-2% -$74.9K 0.04% 511
2022
Q1
$3.8M Sell
95,308
-4,714
-5% -$168K 0.03% 634
2021
Q4
$4.02M Sell
100,022
-738
-0.7% -$27.6K 0.03% 630
2021
Q3
$4.1M Sell
100,760
-5,554
-5% -$232K 0.03% 612
2021
Q2
$4.83M Buy
106,314
+86,287
+431% +$3.82M 0.04% 571
2021
Q1
$835K Sell
20,027
-1,871
-9% -$85.4K 0.03% 673
2020
Q4
$935K Buy
21,898
+776
+4% +$27.9K 0.04% 582
2020
Q3
$555K Sell
21,122
-620
-3% -$17.3K 0.02% 780
2020
Q2
$583K Sell
21,742
-3,095
-12% -$69.8K 0.03% 741
2020
Q1
$447K Sell
24,837
-2,060
-8% -$39.1K 0.01% 962
2019
Q4
$477K Buy
26,897
+1,546
+6% +$26.8K 0.01% 1139
2019
Q3
$393K Sell
25,351
-320
-1% -$5.27K 0.01% 1171
2019
Q2
$441K Buy
25,671
+6,718
+35% +$108K 0.01% 1139
2019
Q1
$305K Buy
18,953
+770
+4% +$12.5K 0.01% 1256
2018
Q4
$266K Buy
+18,183
New +$290K 0.01% 1240
2018
Q3
Sell
-19,053
Closed -$321K 1520
2018
Q2
$321K Buy
19,053
+3,077
+19% +$58.2K 0.01% 1279
2018
Q1
$313K Sell
15,976
-271
-2% -$5.25K 0.01% 1191
2017
Q4
$329K Buy
16,247
+1,029
+7% +$18.9K 0.01% 1217
2017
Q3
$264K Buy
15,218
+1,151
+8% +$15.6K 0.01% 1298
2017
Q2
$180K Buy
14,067
+705
+5% +$9.42K 0.01% 1464
2017
Q1
$173K Sell
13,362
-13
-0.1% -$164 0.01% 1399
2016
Q4
$132K Buy
13,375
+1,842
+16% +$20.2K 0.01% 1438
2016
Q3
$139K Buy
11,533
+15
+0.1% +$153 0.01% 1314
2016
Q2
$117K Buy
11,518
+338
+3% +$3.33K 0.01% 1322
2016
Q1
$106K Buy
11,180
+1,012
+10% +$9.52K 0.01% 1218
2015
Q4
$176K Sell
10,168
-985
-9% -$15.7K 0.02% 1094
2015
Q3
$150K Buy
11,153
+180
+2% +$3.61K 0.02% 1203
2015
Q2
$248K Buy
10,973
+470
+4% +$8.26K 0.02% 1114
2015
Q1
$150K Buy
10,503
+403
+4% +$5.81K 0.02% 893
2014
Q4
$97K Buy
10,100
+16
+0.2% +$142 0.02% 831
2014
Q3
$92K Sell
10,084
-5
-0% -$48 0.01% 819
2014
Q2
$100K Buy
+10,089
New +$85.6K 0.02% 846

Other funds holding HALO

Amalgamated Bank's HALO Position: Q2 2026 in Review

Amalgamated Bank reduced its Halozyme (HALO) stake by 3.9% in Q2 2026, selling an estimated $158K and leaving 56,688 shares worth $4.44M. The position accounts for 0.03% of the portfolio, ranked #494.

Amalgamated Bank first reported a position in HALO in Q2 2014 and has held it in 48 quarters since. The position peaked at $5.42M in Q4 2022. 346 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Amalgamated Bank held 56,688 shares of Halozyme worth $4.44M as of Q2 2026.
  • Amalgamated Bank sold 2,323 Halozyme shares in Q2 2026, an estimated $158K.
  • Halozyme made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #494 holding.
  • Amalgamated Bank first reported a position in Halozyme in Q2 2014 and has held it in 48 quarters since.
  • Amalgamated Bank's Halozyme position peaked at $5.42M in Q4 2022.
  • 346 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.